These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24112998)

  • 1. Body mass index and liver stiffness affect accuracy of ultrasonography in detecting steatosis in patients with chronic hepatitis C virus genotype 1 infection.
    Macaluso FS; Maida M; Cammà C; Cabibi D; Alessi N; Cabibbo G; Di Marco V; Craxì A; Petta S
    Clin Gastroenterol Hepatol; 2014 May; 12(5):878-884.e1. PubMed ID: 24112998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.
    Macaluso FS; Maida M; Cammà C; Cabibbo G; Cabibi D; Alduino R; Di Marco V; Craxì A; Petta S
    J Hepatol; 2014 Sep; 61(3):523-9. PubMed ID: 24815874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of bright liver echo pattern in patients with chronic hepatitis C: correlation with steatosis and fibrosis.
    Loy M; Serra G; Chessa L
    J Ultrasound; 2016; 19(2):91-8. PubMed ID: 27298639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hepatic steatosis by ultrasound in patients with chronic hepatitis C virus infection.
    Hirche TO; Ignee A; Hirche H; Schneider A; Dietrich CF
    Liver Int; 2007 Aug; 27(6):748-57. PubMed ID: 17617117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance?
    Kumar M; Rastogi A; Singh T; Behari C; Gupta E; Garg H; Kumar R; Bhatia V; Sarin SK
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1194-201. PubMed ID: 23425053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
    Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
    Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
    Anty R; Gelsi E; Giudicelli J; Mariné-Barjoan E; Gual P; Benzaken S; Saint-Paul MC; Sadoul JL; Huet PM; Tran A
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):671-7. PubMed ID: 17625437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.
    Petta S; Cammà C; Di Marco V; Alessi N; Barbaria F; Cabibi D; Caldarella R; Ciminnisi S; Licata A; Massenti MF; Mazzola A; Tarantino G; Marchesini G; Craxì A
    Hepatology; 2008 Jul; 48(1):28-37. PubMed ID: 18506842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients.
    Lupşor M; Badea R; Stefănescu H; Grigorescu M; Sparchez Z; Serban A; Branda H; Iancu S; Maniu A
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):155-63. PubMed ID: 18568136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular events in chronic hepatitis C: prognostic value of liver stiffness evolution.
    Serres L; Vasseur P; Tougeron D; Gand E; Chagneau-Derrode C; Charier F; Rochd S; Silvain C
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1286-92. PubMed ID: 26275081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.
    Hézode C; Zafrani ES; Roudot-Thoraval F; Costentin C; Hessami A; Bouvier-Alias M; Medkour F; Pawlostky JM; Lotersztajn S; Mallat A
    Gastroenterology; 2008 Feb; 134(2):432-9. PubMed ID: 18242211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled attenuation parameter for steatosis grading in chronic hepatitis C compared with digital morphometric analysis of liver biopsy: impact of individual elastography measurement quality.
    Mendes LC; Ferreira PA; Miotto N; Zanaga L; Lazarini MS; Gonçales ESL; Pedro MN; Gonçales FL; Stucchi RSB; Vigani AG
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):959-966. PubMed ID: 29727388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive assessment of liver steatosis, fibrosis and inflammation in chronic hepatitis C virus infection.
    Schneider AR; Teuber G; Kriener S; Caspary WF
    Liver Int; 2005 Dec; 25(6):1150-5. PubMed ID: 16343065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Archimandritis AJ
    Dig Liver Dis; 2007 Oct; 39(10):936-42. PubMed ID: 17720637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
    Patton HM; Patel K; Behling C; Bylund D; Blatt LM; Vallée M; Heaton S; Conrad A; Pockros PJ; McHutchison JG
    J Hepatol; 2004 Mar; 40(3):484-90. PubMed ID: 15123364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A diagnostic algorithm for assessment of liver fibrosis by liver stiffness measurement in patients with chronic hepatitis B.
    Cai YJ; Dong JJ; Wang XD; Huang SS; Chen RC; Chen Y; Wang YQ; Song M; Chen YP; Li Z; Zhou MT; Shi KQ
    J Viral Hepat; 2017 Nov; 24(11):1005-1015. PubMed ID: 28419755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
    Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
    Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma.
    Abdelaziz AO; Shousha HI; Said EM; Soliman ZA; Shehata AA; Nabil MM; Abdelmaksoud AH; Elbaz TM; Abdelsalam FM
    Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1384-1388. PubMed ID: 30179227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver stiffness measurement by transient elastography in clinical practice.
    Sporea I; Sirli R; Deleanu A; Popescu A; Cornianu M
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):395-9. PubMed ID: 19104699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.